These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6771386)

  • 1. Cannabinoids. I. Behavioral effects.
    Stark P; Dews PB
    J Pharmacol Exp Ther; 1980 Jul; 214(1):124-30. PubMed ID: 6771386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the agonistic activity of delta 9-11-tetrahydrocannabinol in mice, dogs and rhesus monkeys and its interactions with delta 9-tetrahydrocannabinol.
    Beardsley PM; Scimeca JA; Martin BR
    J Pharmacol Exp Ther; 1987 May; 241(2):521-6. PubMed ID: 3033218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychoactive cannabinoids reduce gastrointestinal propulsion and motility in rodents.
    Shook JE; Burks TF
    J Pharmacol Exp Ther; 1989 May; 249(2):444-9. PubMed ID: 2542532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of cannabinoids in the elevated plus maze.
    Onaivi ES; Green MR; Martin BR
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1002-9. PubMed ID: 2162942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of systemic and intraventricular administration of cannabinoids on schedule-controlled responding in the squirrel monkey.
    Carney JM; Balster RL; Martin BR; Harris LS
    J Pharmacol Exp Ther; 1979 Sep; 210(3):399-404. PubMed ID: 113528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabimimetic activity from CP-47,497, a derivative of 3-phenylcyclohexanol.
    Weissman A; Milne GM; Melvin LS
    J Pharmacol Exp Ther; 1982 Nov; 223(2):516-23. PubMed ID: 6290642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Testing the pharmacological activity of some synthetic cannabinoids in mice (author's transl)].
    Ganz AJ; Waser PG
    Arzneimittelforschung; 1980; 30(3):471-7. PubMed ID: 7387758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid-induced hormone changes in monkeys and rats.
    Rosenkrantz H; Esber HJ
    J Toxicol Environ Health; 1980 Mar; 6(2):297-313. PubMed ID: 6248648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of drugs on behavior in pigeons tolerant to delta 9-tetrahydrocannabinol.
    McMillan DE; Leander JD; Dudley KH
    J Pharmacol Exp Ther; 1980 Jan; 212(1):85-90. PubMed ID: 7351628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of barbiturates in rats tolerant to delta 9-tetrahydrocannabinol.
    McMillan DE; Hardwick WC; Wells JD
    Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):4-14. PubMed ID: 6312913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cannabinoids on levels of acetylcholine and choline and on turnover rate of acetylcholine in various regions of the mouse brain.
    Tripathi HL; Vocci FJ; Brase DA; Dewey WL
    Alcohol Drug Res; 1987; 7(5-6):525-32. PubMed ID: 3620017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose and behavioral context dependent inhibition of movement and basal ganglia neural activity by Delta-9-tetrahydrocannabinol during spontaneous and treadmill locomotion tasks in rats.
    Shi LH; Luo F; Woodward DJ; Chang JY
    Synapse; 2005 Jan; 55(1):1-16. PubMed ID: 15499609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans.
    Hart CL; Ward AS; Haney M; Comer SD; Foltin RW; Fischman MW
    Psychopharmacology (Berl); 2002 Dec; 164(4):407-15. PubMed ID: 12457271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effects of delta-9-tetrahydrocannabinol in rhesus monkeys as measured by performance in a battery of complex operant tests.
    Schulze GE; McMillan DE; Bailey JR; Scallet A; Ali SF; Slikker W; Paule MG
    J Pharmacol Exp Ther; 1988 Apr; 245(1):178-86. PubMed ID: 2834536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of phentermine on responding maintained under multiple fixed-ratio schedules of food and cocaine presentation in the rhesus monkey.
    Wojnicki FH; Rothman RB; Rice KC; Glowa JR
    J Pharmacol Exp Ther; 1999 Feb; 288(2):550-60. PubMed ID: 9918558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Nov; 446():1-317. PubMed ID: 12594529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes.
    Poddar MK; Dewey WL
    J Pharmacol Exp Ther; 1980 Jul; 214(1):63-7. PubMed ID: 7391971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dependence on tetrahydrocannabinol in rhesus monkeys.
    Beardsley PM; Balster RL; Harris LS
    J Pharmacol Exp Ther; 1986 Nov; 239(2):311-9. PubMed ID: 3021952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of natural and synthetic cannabinoids in suppression of humoral and cell-mediated immunity.
    Smith SH; Harris LS; Uwaydah IM; Munson AE
    J Pharmacol Exp Ther; 1978 Oct; 207(1):165-70. PubMed ID: 702337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys.
    Negus SS; Gatch MB; Mello NK; Zhang X; Rice K
    J Pharmacol Exp Ther; 1998 Jul; 286(1):362-75. PubMed ID: 9655881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.